Loading chat...
IN HB1544
Bill
Status
1/18/2017
Primary Sponsor
Steven Davisson
Click for details
AI Summary
HB 1544 Summary
-
Requires state employee health plans, accident and sickness insurance policies, and HMO contracts to cover at least one abuse deterrent opioid analgesic for each available opioid agonist active ingredient.
-
Defines "abuse deterrent opioid analgesic" as a drug formulated with abuse deterrent properties and labeled by the FDA to indicate it deters or reduces drug abuse.
-
Prohibits plans from imposing less favorable copayments, deductibles, or coinsurance on abuse deterrent opioids compared to other prescription drugs in the same category (brand name or generic).
-
Prevents plans from requiring patients to use non-abuse-deterrent opioids first as a condition of coverage for abuse deterrent alternatives.
-
Allows plans to apply utilization review requirements like prior authorization if the same requirements apply to all opioid analgesics with the same release formulation.
-
Effective date: July 1, 2017.
Legislative Description
Coverage for abuse deterrent opioids. Requires that, if an abuse deterrent opioid analgesic is available with a certain active ingredient, state employee health plans, policies of accident and sickness insurance, and health maintenance organization contracts must provide coverage for at least one abuse deterrent opioid analgesic that provides that active ingredient.
Last Action
Representative Shackleford added as coauthor
1/24/2017